| 322098 |
NEURO-ONCOLOGY |
TMOD-17. BRAIN TUMOR PATIENT DERIVED XENOGRAFT FROM LUNG TUMOR METASTASIS: ESTABLISHMENT AND CHARACTERIZATION |
2017-11-01 |
10.1093/neuonc/nox168.1055 |
James C David, Stupp Roger, Lukas Rimas V, Kalapurakal John A, Akhtar-Zaidi Batula, Horbinski Craig M |
| 322097 |
NEURO-ONCOLOGY |
RARE-31. DUAL BRAF/MEK THERAPY FOR PATIENTS WITH BRAF V600E-MUTATED TUMORS: DRAMATIC CLINICAL AND RADIOGRAPHIC RESPONSES AND A REDUCTION IN CUTANEOUS TOXICITY |
2017-11-01 |
10.1093/neuonc/nox168.875 |
Bernstein Aaron, Mrowczynski Oliver, Khalsa Amrit, Ryan Sandra, Chung Catherine, Glantz Michael |
| 322096 |
NEURO-ONCOLOGY |
ACTR-46. AG-120, A FIRST-IN-class MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: UPDATED RESULTS FROM THE PHASE 1 NON-ENHANCING GLIOMA POPULATION |
2017-11-01 |
10.1093/neuonc/nox168.037 |
Mellinghoff Ingo K, Touat Mehdi, Maher Elizabeth, De La Fuente Macarena, Cloughesy Timothy F, Holdhoff Matthias, Cote Gregory M, Burris Howard, Janku Filip, Huang Ray, Young Robert J, Ellingson Benjamin, Nimkar Tara, Jiang Liewen, Ishii Yuko, Choe Sung, Fan Bin, Steelman Lori, Yen Katharine, Bowden Chris, Pandya Susan, Wen Patrick Y |
| 322095 |
BMJ OPEN |
Smoking prevalence and attitudes towards smoking among Estonian physicians: results from cross-sectional studies in 2002 and 2014 |
2017-11-01 |
10.1136/bmjopen-2017-017197 |
Põld Mariliis, Pärna Kersti |
| 322094 |
FUSION ENGINEERING AND DESIGN |
Effect of atmospheric control during MA-HIP process on mechanical properties of oxide dispersion-strengthened Cu alloy | Effect of atmospheric control during MA-HIP process on mechanical properties of oxide dispersion-strengthened Cu alloy |
2017-11-01 |
10.1016/j.fusengdes.2017.04.062 |
Noto H., Yamada T., Hishinuma Y., Muroga T. |
| 322093 |
JOURNAL OF GYNECOLOGIC ONCOLOGY : JGO |
Safety of fertility-sparing surgery for stage I ovarian clear cell carcinoma |
2017-11-01 |
|
박정열 |
| 322092 |
NEURO-ONCOLOGY |
ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY |
2017-11-01 |
10.1093/neuonc/nox168.045 |
Korshoej Anders Rosendal, Hansen Frederik Lundgaard, Slavka Lukacova, Cortnum Søren Ole Stigaard, Lassen-Ramshad Yasmin, Guldberg Trine Lignell, Rahbek Christian, Mikic Nikola, Thielscher Axel, Sørensen Jens Christian Hedemann, von Oettingen Gorm Burckhardt |
| 322091 |
NEURO-ONCOLOGY |
GENE-04. COMPREHENSIVE GENOMIC CHARACTERIZATION OF AGGRESSIVE MENINGIOMAS IDENTIFIES MOLECULAR SIGNATURES THAT PREDICT CLINICAL OUTCOMES |
2017-11-01 |
10.1093/neuonc/nox168.379 |
Vasudevan Harish, Braunstein Steve, Phillips Joanna J, Pekmezci Melike, Wu Ashley, Reis Gerald, Magill Stephen, Chang Susan, Sneed Penny, McDermott Michael, Perry Arie, Raleigh David |
| 322090 |
NEURO-ONCOLOGY |
NIMG-07. UNIFYING MAGNETIC RESONANCE IMAGING SIGNATURE OF EGFR PATHWAY ACTIVATION IN GLIOBLASTOMA CONSISTENT WITH UNIFORMLY AGGRESSIVELY INFILTRATION |
2017-11-01 |
10.1093/neuonc/nox168.586 |
Bakas Spyridon, Binder Zev A, Morrissette Jennifer J D, Akbari Hamed, O’Rourke Donald, Davatzikos Christos |
| 322089 |
NEURO-ONCOLOGY |
DRES-17. BCL3 IS A 19q PASSENGER THAT PREDICTS RESPONSE TO ALKYLATING CHEMOTHERAPY IN GBM |
2017-11-01 |
10.1093/neuonc/nox168.275 |
Wu Longtao, Bernal Giovanna, Cahill Kirk, Pytel Peter, Yamini Bakhtiar |
